News Coverage 06.07.22 Share on Twitter Share on Facebook Share on LinkedIn Three-Arm First-Line Chemoimmunotherapy Study in Patients With Metastatic Pancreatic Cancer Related Announcement, Press Release Biomarkers May Predict Better Treatment Options Announcement PICI Hosts 2024 Spring Scientific Retreat Press Release BostonGene and the Parker Institute for Cancer Immunotherapy Collaborate to Generate Comprehensive Longitudinal Multi-Omic Data for Predicting Immunotherapy Outcomes
Press Release BostonGene and the Parker Institute for Cancer Immunotherapy Collaborate to Generate Comprehensive Longitudinal Multi-Omic Data for Predicting Immunotherapy Outcomes